16 results
PRE 14A
SHPH
Shuttle Pharmaceuticals Holdings Inc
10 Jun 24
Preliminary proxy
6:12am
of Directors and Corporate Governance
Director Biographies
Board of Directors Diversity Matrix
Director Independence
Board Leadership Structure
Board … Independence
As of the date of this proxy statement, Steven Richards, Dr. Chris H. Senanayake, Joshua Schafer and Dr. Bette Jacobs are our independent
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
and qualified, or until their removal, resignation, or death. Executive officers serve at the pleasure of the board of directors.
Director Independence … auditors’ qualifications and independence and (d) the performance of the Company’s internal audit functions and independent auditors, as well as other
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
24 Aug 23
Prospectus supplement
2:00pm
.
Director Independence
In order to qualify for continued listing on Nasdaq, our board of directors must consist of a majority of “independent” directors … ) the independent auditors’ qualifications and independence and (d) the performance of the Company’s internal audit functions and independent auditors
DEF 14A
82hy4x
21 Nov 22
Definitive proxy
5:28pm
DRS
e4ssz g2fwd6fsg2j39
29 Sep 22
Draft registration statement
12:00am
424B4
av8m0qic
31 Aug 22
Prospectus supplement with pricing info
6:16am
S-1/A
f9tagm
23 Jun 22
IPO registration (amended)
5:24pm
S-1
f0x7m25
3 Jun 22
IPO registration
5:32pm
DRS/A
e09cajj9664a78s
26 Apr 22
Draft registration statement (amended)
12:00am
DRS
wampps ftllzii6hixn
16 Sep 19
Draft registration statement
12:00am
- Prev
- 1
- Next